Pharmacokinetic study of levodopa coadministration of lactoferrin in healthy volunteers

Pharmacokinetic study of levodopa coadministration of lactoferrin in healthy volunteers - PK study of levodopa coadministration of lactoferrin

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026787

Enrollment

Registered

2017-03-30

Start date

2017-04-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult

Interventions

Levodopa100mg/beserazide25mg Tablet single dose Lactoferrin powder 1g single dose Levodopa100mg/beserazide25mg Tablet single dose

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy adult

Exclusion criteria

Exclusion criteria: known allergy to milk product Any disorder which needs regular office visit History of severe heart disorders,renal insufficiency, hepatic insufficiency or malignancy Investigators judge as an inadequate subject to enroll this study

Design outcomes

Primary

Measure	Time frame
AUC, Cmax, tmax, elimination half-life of levodopa	—

Countries

Japan

Contacts

Public ContactMASAHIRO NAGAI

Ehime university Department of Neurology and Clinical Pharmacology

mnagai@m.ehime-u.ac.jp089-960-5095

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026